Activity of Selected Group of Monoterpenes in Alzheimer’s Disease Symptoms in Experimental Model Studies—A Non-Systematic Review

Alzheimer’s disease (AD) is the leading cause of dementia and cognitive function impairment. The multi-faced character of AD requires new drug solutions based on substances that incorporate a wide range of activities. Antioxidants, AChE/BChE inhibitors, BACE1, or anti-amyloid platelet aggregation su...

Descripción completa

Detalles Bibliográficos
Autores principales: Wojtunik-Kulesza, Karolina, Rudkowska, Monika, Kasprzak-Drozd, Kamila, Oniszczuk, Anna, Borowicz-Reutt, Kinga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306454/
https://www.ncbi.nlm.nih.gov/pubmed/34298986
http://dx.doi.org/10.3390/ijms22147366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306454/
https://www.ncbi.nlm.nih.gov/pubmed/34298986
http://dx.doi.org/10.3390/ijms22147366

Ejemplares similares